Cresent Sucrotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 23-10-2024
- Paid Up Capital ₹ 1.10 M
as on 23-10-2024
- Company Age 33 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.75 Cr
as on 23-10-2024
- Revenue 1.82%
(FY 2023)
- Profit 43.36%
(FY 2023)
- Ebitda 34.09%
(FY 2023)
- Net Worth -1280.11%
(FY 2023)
- Total Assets 33.54%
(FY 2023)
About Cresent Sucrotech
The Company is engaged in the Home & Lifestyle Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.10 M.
The company currently has active open charges totaling ₹1.75 Cr.
Umesh Chopra, Sharda Chopra, and Naman Chopra serve as directors at the Company.
- CIN/LLPIN
U29304UP1991PTC013041
- Company No.
013041
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cresent Sucrotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Chopra  | Director | 01-Mar-1994 | Current |
| Naman Chopra | Director | 15-May-2014 | Current |
| Sharda Chopra | Director | 01-Mar-1994 | Current |
Financial Performance of Cresent Sucrotech.
Cresent Sucrotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.82% increase. The company also saw a substantial improvement in profitability, with a 43.36% increase in profit. The company's net worth observed a substantial decline by a decrease of 1280.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cresent Sucrotech?
In 2023, Cresent Sucrotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cheffon Promoters And Developers Private LimitedActive 17 years 1 monthUmesh Chopra and Sharda Chopra are mutual person
- New Port Resorts Private LimitedActive 27 years 8 months
Umesh Chopra, Sharda Chopra and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 09 Mar 2002 | ₹1.60 Cr | Open |
U.C.O. Bank Creation Date: 05 Nov 1998 | ₹1.50 M | Open |
How Many Employees Work at Cresent Sucrotech?
Unlock and access historical data on people associated with Cresent Sucrotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cresent Sucrotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cresent Sucrotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
